CIK 0001477449
- Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043705970
- Phone
- +1 203-635-2002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-04 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Sale 10b5-1 | −20,773 | $7.26 | $151K | 20,773 |
| 2024-09-03 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Sale | −1,617 | $7.16 | $12K | 41,546 |
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise | +1,056 | 38,715 | ||
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise | +1,348 | 40,063 | ||
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise | +3,100 | 43,163 | ||
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Performance Stock Units | −1,056 | 6,341 | ||
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Restricted Stock Units | −1,348 | 2,696 | ||
| 2024-08-30 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Restricted Stock Units | −3,100 | 18,602 | ||
| 2024-06-03 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Sale | −1,627 | $11.16 | $18K | 37,659 |
| 2024-05-31 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise | +1,056 | 34,838 | ||
| 2024-05-31 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise | +1,348 | 36,186 | ||
| 2024-05-31 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise | +3,100 | 39,286 | ||
| 2024-05-31 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Performance Stock Units | −1,056 | 7,397 | ||
| 2024-05-31 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Restricted Stock Units | −1,348 | 4,044 | ||
| 2024-05-31 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise · Restricted Stock Units | −3,100 | 21,702 | ||
| 2024-03-19 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Grant or award · Restricted Stock Units | +43,800 | 43,800 | ||
| 2024-03-05 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Sale 10b5-1 | −5,647 | $14.53 | $82K | 33,782 |
| 2024-03-04 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Sale 10b5-1 | −6,190 | $14.52 | $90K | 39,429 |
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Sale 10b5-1 | −475 | $15.06 | $7K | 25,193 |
| 2024-03-01 | Turitz Andrew EVP, CORPORATE DEVELOPMENT | Option exercise 10b5-1 | +4,226 | 29,419 |
Page 1 of 9 · 167 trades